This is the sixth video of CARDIOPATCH Network. All the partners will explain their role in the project and how they contribute to the success of the initiative.
Raquel Fortunato, CEO of Genibet, explain the role of the partner IBET.
CARDIOPATCH Excellent Network born to advance in the field of Cardiac Regenerative Medicine and 3D printing applied to Myocardial Infarction treatment.
Co-funded by the Interreg Sudoe Programme through the European Regional Development Fund (ERDF), CARDIOPATCH is fostered by 9 different partners from 6 different regions of Spain, France and Portugal: the Center for Applied Medical Research (CIMA) of Navarra University, the University Clinic of Navarra (CUN), GenIbet Biopharmaceuticals, GUK communication agency, the Toulouse University Hospital (CHUT), the Research Institute of the Hospital de la Santa Creu i Sant Pau, the Instituto de Biologia Experimental e Tecnológica (iBET), the Institute of Biomolecules Max Mousseron (IBMM) and Leartiker Technogical Centre.
[ Ссылка ]
![](https://s2.save4k.ru/pic/9GWa3a8YlR0/maxresdefault.jpg)